Profile
| Role | Insider |
|---|---|
| Notability | 20/100 |
Board memberships
- Rocket Pharmaceuticals, Inc.
Updated Jul 16, 2026
Militello John has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $202K.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-21 | RCKT | ROCKET PHARMACEUTICALS, INC. | S — Open-market sale | 384 | $3.01 | $1K |
| 2026-05-14 | RCKT | ROCKET PHARMACEUTICALS, INC. | S — Open-market sale | 855 | $3.61 | $3K |
| 2026-02-20 | RCKT | ROCKET PHARMACEUTICALS, INC. | S — Open-market sale | 1.2K | $3.34 | $4K |
| 2026-02-18 | RCKT | ROCKET PHARMACEUTICALS, INC. | S — Open-market sale | 3.7K | $3.31 | $12K |
| 2026-02-13 | RCKT | ROCKET PHARMACEUTICALS, INC. | A — Grant or award | 30.0K | $0.00 | |
| 2025-10-14 | RCKT | ROCKET PHARMACEUTICALS, INC. | S — Open-market sale | 558 | $3.98 | $2K |
| 2025-10-14 | RCKT | ROCKET PHARMACEUTICALS, INC. | S — Open-market sale | 3.0K | $3.97 | $12K |
| 2025-10-14 | RCKT | ROCKET PHARMACEUTICALS, INC. | S — Open-market sale | 5.5K | $3.96 | $22K |
| 2025-10-14 | RCKT | ROCKET PHARMACEUTICALS, INC. | S — Open-market sale | 19.8K | $3.96 | $79K |
| 2025-09-08 | RCKT | ROCKET PHARMACEUTICALS, INC. | A — Grant or award | 40.0K | $0.00 | |
| 2025-08-18 | RCKT | ROCKET PHARMACEUTICALS, INC. | S — Open-market sale | 361 | $3.00 | $1K |
| 2025-08-18 | RCKT | ROCKET PHARMACEUTICALS, INC. | S — Open-market sale | 699 | $3.06 | $2K |
| 2025-08-14 | RCKT | ROCKET PHARMACEUTICALS, INC. | S — Open-market sale | 7.0K | $3.02 | $21K |
| 2025-05-20 | RCKT | ROCKET PHARMACEUTICALS, INC. | S — Open-market sale | 357 | $6.45 | $2K |
| 2025-05-16 | RCKT | ROCKET PHARMACEUTICALS, INC. | S — Open-market sale | 655 | $6.53 | $4K |
| 2025-04-22 | RCKT | ROCKET PHARMACEUTICALS, INC. | S — Open-market sale | 718 | $7.16 | $5K |
| 2024-11-25 | RCKT | ROCKET PHARMACEUTICALS, INC. | S — Open-market sale | 1.2K | $13.05 | $16K |
| 2024-11-04 | RCKT | ROCKET PHARMACEUTICALS, INC. | S — Open-market sale | 917 | $16.62 | $15K |
Militello John is a corporate insider — currently tracked as Insider of ROCKET PHARMACEUTICALS, INC. (RCKT). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 16 open-market sales ($202K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Militello John profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.